{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:57:49Z","timestamp":1793923069426,"version":"4.8.0"},"reference-count":37,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T00:00:00Z","timestamp":1740268800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Early-type drug hypersensitivity reactions (DHRs) are observed within the first 1\u20136 h and most commonly manifest as urticaria and\/or angioedema. Detailed anamnesis, skin prick tests (SPTs), intradermal tests (IDTs), and oral\/intramuscular\/intravenous drug provocation tests (DPTs) can be used to identify the drug responsible. We aimed to evaluate the demographic characteristics, responsible drugs, DHR types, and DPT results used in the diagnosis of drug allergy in patients who presented to our clinic with suspected drug allergies. Materials and Methods: The medical records of patients who presented with a suspicion of an early-type DHR between February 2019 and December 2024 were retrospectively evaluated through the hospital information management system. A total of 188 adults who underwent diagnostic drug testing were included. Results: The diagnosis of drug allergy was confirmed in 51 (27%) patients. In 137 (73%) patients, the diagnosis of drug allergy was excluded after DPTs. In 78 of the 188 patients, there was a DHR to a single suspected drug. The other 110 patients had DHR histories with multiple drugs. The rate of confirmation of a drug allergy from diagnostic tests was higher in those who described a history of multiple drug allergies. Amongst the antibiotics, beta-lactam antibiotics (n = 47) were the most frequently suspected drugs. The rate of positive DPTs (n = 4; 8%) was lower in patients with suspected beta-lactam allergies than other antibiotics (p = 0.002). NSAIDs (n = 60) were the second most common group of suspected drug allergies. With regard to IgE or COX-1-mediated mechanisms, there was no statistically significant difference in DPT positivity among these NSAIDs (p = 0.414). The severity of the initial early-type DHRs were grade 1 (n = 168; 80%), grade 2 (n = 14; 7%), and grade 3 (n = 14; 7%). If the patients had redness, itching, urticaria, angioedema, dyspnea, cyanosis, desaturation, syncope, tachycardia, or hypotension during their initial DHRs, the positive diagnostic drug test rate was statistically significantly higher. However, experiencing diarrhea, nausea, and vomiting were not found to be associated with positive diagnostic drug tests. Drug allergies were confirmed with SPTs or IDTs in all patients in whom adrenaline was used during initial reactions. Conclusions: Contrary to the prevailing notion that drugs (especially beta-lactams) are the predominant cause of allergic reactions, this study demonstrated that the actual prevalence of drug allergies is, in fact, low.<\/jats:p>","DOI":"10.3390\/medicina61030386","type":"journal-article","created":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T10:04:28Z","timestamp":1740391468000},"page":"386","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Is a Drug Allergy in a Patient\u2019s History Real? Our Experience with Diagnostic Drug Provocation Tests"],"prefix":"10.3390","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6200-0909","authenticated-orcid":false,"given":"Begum","family":"Gorgulu Akin","sequence":"first","affiliation":[{"name":"Department of Immunology and Allergic Diseases, Ankara Bilkent City Hospital, 06800 Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8653-3497","authenticated-orcid":false,"given":"Betul","family":"Ozdel Ozturk","sequence":"additional","affiliation":[{"name":"Department of Immunology and Allergic Diseases, Ankara Bilkent City Hospital, 06800 Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8272-5686","authenticated-orcid":false,"given":"Makbule Seda","family":"Bayrak Durmaz","sequence":"additional","affiliation":[{"name":"Department of Immunology and Allergic Diseases, Ankara Bilkent City Hospital, 06800 Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1939-2636","authenticated-orcid":false,"given":"Ozge","family":"Ozturk Aktas","sequence":"additional","affiliation":[{"name":"Division of Allergy and Clinical Immunology, Ankara Bilkent City Hospital, School of Medicine, Ankara Yildirim Beyazit University, 06800 Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3270-5884","authenticated-orcid":false,"given":"Sadan","family":"Soyyigit","sequence":"additional","affiliation":[{"name":"Division of Allergy and Clinical Immunology, Ankara Bilkent City Hospital, School of Medicine, Ankara Yildirim Beyazit University, 06800 Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,2,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jaci.2003.12.591","article-title":"Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003","volume":"113","author":"Johansson","year":"2004","journal-title":"J. Allergy Clin. Immunol. Glob."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.pop.2016.04.005","article-title":"Drug allergy","volume":"43","author":"Waheed","year":"2016","journal-title":"Prim. Care"},{"key":"ref_3","unstructured":"Kommu, S., and Whitfield, P. (2024). Adverse Drug Reactions. StatPearls [Internet], StatPearls Publishing."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/01.all.0000011031.16814.e0","article-title":"Epidemiology of drug allergy","volume":"1","author":"Demoly","year":"2001","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"ref_5","first-page":"759","article-title":"Erken tip ila\u00e7 alerjisi s\u0131kl\u0131\u011f\u0131n\u0131n ve test sonu\u00e7lar\u0131n\u0131n de\u011ferlendirilmesi: Sakarya b\u00f6lgesinden retrospektif bir \u00e7al\u0131\u015fma","volume":"8","author":"Sancar","year":"2018","journal-title":"Sak. T\u0131p Derg."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/all.12350","article-title":"International Consensus on drug allergy","volume":"69","author":"Demoly","year":"2014","journal-title":"Allergy"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"136","DOI":"10.19161\/etd.418143","article-title":"Erken tip ila\u00e7 reaksiyonlar\u0131nda be\u015f y\u0131ll\u0131k \u00c7ukurova \u00dcniversitesi \u00c7ocuk Alerji Klini\u011fi deneyimi","volume":"57","year":"2018","journal-title":"Ege T\u0131p Derg."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1001\/jama.279.15.1200","article-title":"Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies","volume":"279","author":"Lazarou","year":"1998","journal-title":"JAMA"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/all.15996","article-title":"EAACI\/ENDA position paper on drug provocation testing","volume":"79","author":"Barbaud","year":"2024","journal-title":"Allergy"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/all.12142","article-title":"Skin test concentrations for systemically administered drugs\u2013an ENDA\/EAACI Drug Allergy Interest Group position paper","volume":"68","author":"Brockow","year":"2013","journal-title":"Allergy"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jaci.2004.04.029","article-title":"Clinical features and severity grading of anaphylaxis","volume":"114","author":"Brown","year":"2004","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"975","DOI":"10.5858\/2009-0518-OA.1","article-title":"Proficiency survey-based evaluation of clinical total and allergen-specific IgE assay performance","volume":"134","author":"Hamilton","year":"2010","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1034\/j.1398-9995.2003.00280.x","article-title":"Diagnosis of immediate allergic reactions to beta-lactam antibiotics","volume":"58","author":"Torres","year":"2003","journal-title":"Allergy"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1080\/1744666X.2019.1619548","article-title":"Allergic reactions to penicillins and cephalosporins: Diagnosis, assessment of cross-reactivity and management","volume":"15","author":"Somoza","year":"2019","journal-title":"Expert Rev. Clin. Immunol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1111\/all.13721","article-title":"A EAACI drug allergy interest group survey on how European allergy specialists deal with \u03b2-lactam allergy","volume":"74","author":"Torres","year":"2019","journal-title":"Allergy"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/all.13599","article-title":"Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD)\u2014A EAACI position paper","volume":"74","author":"Kowalski","year":"2019","journal-title":"Allergy"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2165\/00151829-200605060-00005","article-title":"Use of nonsteroidal anti-inflammatory drugs in patients with aspirin hypersensitivity: Safety of cyclo-oxygenase-2 inhibitors","volume":"5","author":"Kowalski","year":"2006","journal-title":"Treat. Respir. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jaip.2018.07.051","article-title":"Controversies in drug allergy: Beta-lactam hypersensitivity testing","volume":"7","author":"Torres","year":"2019","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1080\/14787210.2019.1617132","article-title":"Self-reported beta-lactam intolerance: Not a class effect, dangerous to patients, and rarely allergy","volume":"17","author":"Vyles","year":"2019","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/j.jaip.2019.03.015","article-title":"Identifying low-risk beta-lactam allergy patients in a UK tertiary centre","volume":"7","author":"Siew","year":"2019","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.anai.2016.04.021","article-title":"Penicillin skin testing in hospitalized patients with \u03b2-lactam allergies: Effect on antibiotic selection and cost","volume":"117","author":"King","year":"2016","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"292","DOI":"10.18176\/jiaci.0669","article-title":"Clinical practice guidelines for diagnosis and management of hypersensitivity reactions to quinolones","volume":"31","year":"2021","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1016\/j.jaip.2020.04.051","article-title":"Clinical characterization and diagnostic approaches for patients reporting hypersensitivity reactions to quinolones","volume":"8","author":"Salas","year":"2020","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"347","DOI":"10.4168\/aair.2017.9.4.347","article-title":"Usefulness of in vivo and in vitro diagnostic tests in the diagnosis of hypersensitivity reactions to quinolones and in the evaluation of cross-reactivity: A comprehensive study including the latest quinolone gemifloxacin","volume":"9","author":"Demir","year":"2017","journal-title":"Allergy Asthma Immunol. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.anai.2020.04.003","article-title":"Results of NSAID provocation tests and difficulties in the classification of children with nonsteroidal anti-inflammatory drug hypersensitivity","volume":"125","author":"Topal","year":"2020","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1016\/j.bja.2022.07.039","article-title":"Drug provocation tests with hypnotics, opioids, and neuromuscular blocking agents in the diagnosis of suspected perioperative hypersensitivity","volume":"129","author":"Vlaeminck","year":"2022","journal-title":"Br. J. Anaesth."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e126","DOI":"10.1016\/j.bja.2019.03.018","article-title":"The use of drug provocation testing in the investigation of suspected immediate perioperative allergic reactions: Current status","volume":"123","author":"Garvey","year":"2019","journal-title":"Br. J. Anaesth."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7812\/TPP\/21.058","article-title":"Practical management of new-onset urticaria and angioedema presenting in primary care, urgent care, and the emergency department","volume":"25","author":"Macy","year":"2021","journal-title":"Perm. J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"438","DOI":"10.5021\/ad.2019.31.4.438","article-title":"Anaphylaxis to chlorpheniramine maleate and literature review","volume":"31","author":"Choi","year":"2019","journal-title":"Ann. Dermatol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/j.1398-9995.1998.tb03982.x","article-title":"Anaphylactic reaction due to diphenhydramine","volume":"53","author":"Barranco","year":"1998","journal-title":"Allergy"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s12016-013-8365-z","article-title":"Hypersensitivity reactions to corticosteroids","volume":"47","author":"Vatti","year":"2014","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1016\/j.jaip.2023.09.031","article-title":"Drug allergy in women","volume":"11","author":"Lee","year":"2023","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.1016\/j.jaip.2023.10.014","article-title":"Women\u2019s Health in Allergy\/Immunology and Women in Allergy\/Immunology","volume":"11","author":"Ramsey","year":"2023","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"210067","DOI":"10.1183\/16000617.0067-2021","article-title":"Sex and gender in asthma","volume":"30","author":"Chowdhury","year":"2021","journal-title":"Eur. Respir. Rev."},{"key":"ref_35","first-page":"357","article-title":"6 Self-reported Drug Allergy in Health Care Workers in Conservative and Surgical Medicine Departments","volume":"22","author":"Zilinskaite","year":"2012","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"key":"ref_36","first-page":"82","article-title":"Occupational allergy in the production of drugs","volume":"45","author":"Rembadel","year":"1990","journal-title":"Pol. Tyg. Lek."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1034\/j.1398-9995.2003.00291.x","article-title":"Drug allergy in university students from Porto, Portugal","volume":"58","author":"Falcao","year":"2003","journal-title":"Allergy"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/3\/386\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:40:55Z","timestamp":1760028055000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/3\/386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,23]]},"references-count":37,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["medicina61030386"],"URL":"https:\/\/doi.org\/10.3390\/medicina61030386","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,23]]}}}